Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
3
Bearish filings
17
Named actors
10
Disclosed $ (bull / bear)
$3.9M / $2.7M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-27 | Director Ciongoli Gregory Austin | bought | $500K | SEC ↗ |
| 2026-08-26 | Director Ciongoli Gregory Austin | bought | $450K | SEC ↗ |
| 2026-07-17 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-07-16 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-07-02 | Chief Medical Officer PAKOLA STEVE | sold | $29K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-07-01 |
| Chief Medical Officer PAKOLA STEVE |
| sold |
| $472K |
| SEC ↗ |
| 2026-07-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Stephen J. Pakola | filed notice to sell | $518K | SEC ↗ |
| 2026-06-29 | Chief Medical Officer PAKOLA STEVE | sold | $216K | SEC ↗ |
| 2026-05-11 | Chief Medical Officer PAKOLA STEVE | sold | $169K | SEC ↗ |
| 2026-05-11 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) STEPHEN PAKOLA | filed notice to sell | $368K | SEC ↗ |
| 2026-03-10 | Chief Medical Officer PAKOLA STEVE | sold | $53K | SEC ↗ |
| 2026-03-10 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) STEPHEN J PAKOLA | filed notice to sell | $53K | SEC ↗ |
| 2026-03-05 | Executive Vice President, Chief Medical Officer Stephen Pakola, M.D. | adopted a selling plan | — | SEC ↗ |
| 2026-01-27 | Insider Mills Kenneth T. | exercised options & held the shares | $2.9M | — |
| 2025-11-06 | Chief Financial Officer Mitchell Chan | adopted a selling plan | — | SEC ↗ |
| 2025-10-09 | Chief Executive Officer Simpson Curran | sold | $263K | SEC ↗ |
| 2025-10-09 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) CURRAN M SIMPSON | filed notice to sell | $254K | SEC ↗ |
| 2025-09-29 | Chief Executive Officer Simpson Curran | sold | $76K | SEC ↗ |
| 2025-09-10 | Chief Executive Officer Simpson Curran | sold | $77K | SEC ↗ |
| 2025-09-10 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) CURRAN M SIMPSON | filed notice to sell | $152K | SEC ↗ |